Larson Financial Group’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
Larson Financial Group's CAPR Position: Q3 2026 in Review
Larson Financial Group increased its Capricor Therapeutics (CAPR) stake by 2,288% in Q3 2026, buying an estimated $10.4K and bringing the position to 979 shares worth $9.27K. The position accounts for ﹤0.01% of the portfolio, ranked #2553.
Larson Financial Group first reported a position in CAPR in Q1 2026 and has held it in 3 quarters since. 158 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.
- Larson Financial Group held 979 shares of Capricor Therapeutics worth $9.27K as of Q3 2026.
- Larson Financial Group bought 938 Capricor Therapeutics shares in Q3 2026, an estimated $10.4K.
- Capricor Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2553 holding.
- Larson Financial Group first reported a position in Capricor Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 158 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.